Jordan Collaborating Cardiology Group Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT03021343
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Jordan Collaborating Cardiology Group